Development of a Research Agenda for Inferior Vena Cava Filters: Proceedings from a Multidisciplinary Research Consensus Panel

Journal of Vascular and Interventional Radiology

Volumn 20, Issue 6, 2009, Pages 697-707

  Kaufman, John A ^a   Rundback, John H ^b   Kee, Stephen T ^c   Geerts, William ^d   Gillespie, David ^g   Kahn, Susan R ^f   Kearon, Clive ^e   Rectenwald, John ^h   Rogers, Frederick B ⁱ   Stavropoulos, S William ^j   Streiff, Michael ^k   Vedantham, Suresh ^l   Venbrux, Anthony ^m  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b New York Presbyterian Hospital Columbia University Medical Center   (United States)

^c UCLA MEDICAL CENTER   (United States)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

^f MCGILL UNIVERSITY   (Canada)

^g WALTER REED ARMY MEDICAL CENTER   (United States)

^h UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

ⁱ UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^j HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^k JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTITHROMBIN DEFICIENCY; ARTICLE; ARTIFICIAL EMBOLISM; CARDIOVASCULAR RISK; CLINICAL TRIAL; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HUMAN; INFERIOR CAVA VEIN; LOW DRUG DOSE; LUNG EMBOLISM; MEDICAL INFORMATION; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; PARTIAL THROMBOPLASTIN TIME; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; PROPHYLAXIS; PULMONARY HYPERTENSION; RECURRENT DISEASE; TREATMENT OUTCOME; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM;

EID: 65649151429     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2009.03.007     Document Type: Note

References (86)

1. Jaff M.R., Goldhaber S.Z., and Tapson V.F. High utilization rate of vena cava filters in deep vein thrombosis. Thromb Haemost 93 (2005) 1117-1119
2. Ansell J. Vena cava filters: do we know all that we need to know?. Circulation 112 (2005) 298-299
3. Girard P., Tardy B., and Decousus H. Inferior vena cava interruption: how and when?. Annu Rev Med 51 (2000) 1-15
4. Cushman M.C., Tsai A.W., White R.H., et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 117 (2004) 19-25
5. Naess I.A., Christiansen S.C., Romunstad P., et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 5 (2007) 692-699
6. White R.H., Zhou H., Murin S., et al. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 93 (2005) 298-305
7. Rosendaal F.R. Venous thrombosis: prevalence and interaction of risk factors. Haemostasis 29 (1999) 1-9
8. Seligsohn U., and Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 344 (2001) 1222-1231
9. De Stefano V., Rossi E., Paciaroni K., et al. Screening for inherited thrombophilia: indications and therapeutic implications. Haematologica 87 (2002) 1095-1108
10. Langlois N.J., and Wells P.S. Risk of venous thromboembolism in relatives of symptomatic probands with thrombophilia: a systematic review. Thromb Haemost 90 (2003) 17-26
11. Nossent A.Y., Eikenboom J.C., and Bertina R.M. Plasma coagulation factor levels in venous thrombosis. Semin Hematol 44 (2007) 77-84
12. Koster T., Blann A.D., Briet E., et al. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345 (1995) 152-155
13. van Hylckama Vlieg A., van der Linden I.K., Bertina R.M., et al. High levels of factor IX increase the risk of venous thrombosis. Blood 95 (2000) 3678-3682
14. Meijers J.C., Tekelenburg W.L., Bouma B.N., et al. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 342 (2000) 696-701
15. Andreescu A.C., Cushman M., and Roseendal F.R. D-dimer as a risk factor for deep vein thrombosis: the Leiden Thrombophilia Study. Thromb Haemost 87 (2002) 47-51
16. Cushman M., Folsom A.R., Wang L., et al. Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood 101 (2003) 1243-1248
17. Heit J.A., Silverstein M.D., Mohr D.N., et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 160 (2000) 809-815
18. Alikhan R., Cohen A.T., Combe S., et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med 164 (2004) 963-968
19. White R.H., Zhou H., and Romano P.S. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost 90 (2003) 446-455
20. Geerts W.H., Bergqvist D., Pineo G.F., et al. Prevention of venous thromboembolism. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133 suppl (2008) 381S-453S
21. Owings J.T., Kraut E., Battistella F., et al. Timing of the occurrence of pulmonary embolism in trauma patients. Arch Surg 132 (1992) 862-866
22. Agnelli G., Bolis G., Capussotti L., et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 243 (2006) 89-95
23. Blom J.W., Doggen C.J., Osanto S., et al. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293 (2005) 715-722
24. Hillen H.F. Thrombosis in cancer patients. Ann Oncol 11 suppl 3 (2000) 273-276
25. James A.H., Jamison M.G., Brancazio L.R., and Myers E.R. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 194 (2006) 1311-1315
26. Rosendaal F.R., Van Hylckama Vlieg A., Tanis B.C., and Helmerhorst F.M. Estrogens, progestogens and thrombosis. J Thromb Haemost 1 (2003) 1371-1380
27. Rosendaal F.R. Risk factors for venous thrombotic disease. Thromb Haemost 82 (1999) 610-619
28. Abdollahi M., Cushman M., and Rosendaal F.R. Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost 89 (2003) 493-498
29. Goldhaber S.Z., Grodstein F., Stampfer M.J., et al. A prospective study of risk factors for pulmonary embolism in women. JAMA 277 (1997) 642-645
30. Prandoni P., Bilora F., Marchiori A., et al. An association between atherosclerosis and venous thrombosis. N Engl J Med 348 (2003) 1435-1441
31. Ageno W., Prandoni P., Romualdi E., et al. The metabolic syndrome and the risk of venous thrombosis: a case-control study. J Thromb Haemost 4 (2006) 1914-1918
32. Ay C., Tengler T., Vormittaq R., et al. Venous thromboembolism-a manifestation of the metabolic syndrome. Haematologica 92 (2007) 374-380
33. van der Hagen P.B., Folsom A.R., Jenny N.S., et al. Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health Study. J Thromb Haemost 4 (2006) 1903-1908
34. Ray J.G. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med 158 (1998) 2101-2106
35. de Groot P.G., Lutters B., Derksen R.H., Lisman T., Meijers J.C., and Rosendaal F.R. Lupus anticoagulants and the risk of a first episode of deep venous thrombosis. J Thromb Haemost 3 (2005) 1993-1997
36. Douketis J.D., Kearon C., Bates S., Duku E.K., and Ginsberg J.S. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 279 (1998) 458-462
37. Goldhaber S.Z., Visani L., and De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 353 (1999) 1386-1389
38. Wicki J., Perrier A., Perneger T.V., Bounameaux H., and Junod A.F. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost 84 (2000) 548-552
39. Prandoni P., Noventa F., Ghirarduzzi A., et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism: a prospective cohort study in 1,626 patients. Haematologica 92 (2007) 199-205
40. Heit J.A., Mohr D.N., Silverstein M.D., Petterson T.M., O'Fallon W.M., and Melton III L.J. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 160 (2000) 761-768
41. Baglin T., Luddington R., Brown K., and Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 362 (2003) 523-526
42. Kearon C. Long-term management of patients after venous thromboembolism. Circulation 110 9 suppl 1 (2004) I10-I18
43. Christiansen S.C., Cannegieter S.C., Koster T., Vandenbroucke J.P., and Rosendaal F.R. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 293 (2005) 2352-2361
44. Santamaria M.G., Agnelli G., Taliani M.R., et al. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment. Thromb Res 116 (2005) 301-306
45. Schulman S., Svenungsson E., and Granqvist S. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. Am J Med 104 (1998) 332-338
46. Kearon C., Gent M., Hirsh J., et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 340 (1999) 901-907
47. Prandoni P., Lensing A.W., Cogo A., et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 125 (1996) 1-7
48. Kahn S.R., Kearon C., Julian J.A., et al. Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis. J Thromb Haemost 3 (2005) 718-723
49. Prandoni P., Lensing A.W., Prins M.H., et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med 141 (2004) 249-256
50. Brandjes D.P., Buller H.R., Heijboer H., et al. Randomized trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 34 (1997) 759-762
51. Pengo V., Lensing A.W., Prins M.H., et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 350 (2004) 2257-2264
52. Kearon C., Kahn S.R., Agnelli G., Goldhaber, Raskob G.E., and Comerota A.J. Antithrombotic therapy for venous thromboembolic disease. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133 suppl (2008) 454S-545S
53. van Dongen C.J., van den Belt A.G., Prins M.H., and Lensing A.W. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev (2004) CD001100
54. Lee A.Y., Levine M.N., Baker R.I., et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 349 (2003) 146-153
55. Linkins L.A., Choi P.T., and Douketis J.D. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med 139 (2003) 893-900
56. Agnelli G., Prandoni P., Santamaria M.G., et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. N Engl J Med 345 (2001) 165-169
57. Yu H.T., Dylan M.L., Lin J., and Dubois R.W. Hospitals' compliance with prophylaxis guidelines for venous thromboembolism. Am J Health Syst Pharm 64 (2007) 69-76
58. Buller H.R., Agnelli G., Hull R.D., Hyers T.M., Prins M.H., and Raskob G.E. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 suppl 3 (2004) 401S-428S
59. Kinney T.B. Update on inferior vena cava filters. J Vasc Interv Radiol 14 (2003) 425-440
60. Greenfield L., and Rutherford R. Recommended reporting standards for vena caval filter placement and patient follow-up. Vena Caval Filter Consensus Conference. J Vasc Interv Radiol 10 (1999) 1013-1019
61. Greenfield L., and Proctor M. Filter complications and their management. Semin Vasc Surg 13 (2000) 213-216
62. Pacouret G., Alison D., Pottier J.M., Bertrand P., and Charbonnier B. Free-floating thrombus and embolic risk in patients with angiographically confirmed proximal deep venous thrombosis: a prospective study. Arch Intern Med 157 (1997) 305-308
63. Girard T., Philbrick J., Fritz Angle J., and Becker D.M. Prophylactic vena cava filters for trauma patients: a systematic review of the literature. Thromb Res 112 (2003) 261-267
64. Grande W.J., Trerotola S.O., Reilly P.M., et al. Experience with the recovery filter as a retrievable inferior vena cava filter. J Vasc Interv Radiol 16 (2005) 1189-1193
65. Ray C.E., Mitchell E., Zipser S., Kao E.Y., Brown C.F., and Moneta G.L. Outcomes with retrievable inferior vena cava filters: a multicenter study. J Vasc Interv Radiol 17 (2006) 1595-1604
66. Athanasoulis C.A., Kaufman J.A., Halpern E.F., Waltman A.C., Geller S.C., and Fan C.M. Inferior vena cava filters: review of a 26-year single-center clinical experience. Radiology 216 (2000) 54-66
67. White R.H., Zhou H., Kim J., and Romano P.S. A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism. Arch Intern Med 160 (2000) 2033-2041
68. Karmy-Jones R., Jurkovich G.J., Velmahos G.C., et al. Practice patterns and outcomes of retrievable vena cava filters in trauma patients: an AAST multicenter study. J Trauma 62 (2007) 17-24
69. Piano G., Ketteler E.R., Prachand V., et al. Safety, feasibility, and outcome of retrievable vena cava filters in high-risk surgical patients. J Vasc Surg 45 (2007) 784-788
70. Decousus H., Leizorovicz A., Parent F., et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 338 (1998) 409-415
71. The PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation 112 (2005) 416-422
72. Kaufman J. Retrievable vena cava filters. Tech Vasc Interv Radiol 7 (2004) 96-104
73. Hann C.L., and Streiff M.B. The role of vena cava filters in the management of venous thromboembolism. Blood Rev 19 (2005) 179-202
74. Greenfield L., and Proctor M. Recurrent thromboembolism in patients with vena cava filters. J Vasc Surg 33 (2001) 510-514
75. Christie D.B., Kang J., Ashley D.W., et al. Accelerated migration and proliferation of smooth muscle cells cultured from neointima induced by a vena cava filter. Am Surg (2006) 72491-72496
76. Swaminathan T.N., Hu H.H., and Patel A.A. Numerical analysis of the hemodynamics and embolus capture of a greenfield vena cava filter. J Biomech Eng 128 (2006) 360-370
77. Couch G.G., Johnston K.W., and Ojha M. An in vitro comparison of the hemodynamics of two inferior vena cava filters. J Vasc Surg 31 (2000) 539-549
78. Stein P.D., Alnas M., Skaf E., et al. Outcome and complications of retrievable inferior vena cava filters. Am J Cardiol 94 (2004) 1090-1093
79. Kearon C. Natural history of venous thromboembolism. Circulation 107 23 suppl 1 (2003) I22-I30
80. Greenfield L. Caval interruption procedures. In: Rutherford R.B. (Ed). Vascular surgery. 2nd ed. (2000), WB Saunders, Philadelphia 1968-1978
81. Greenfield L.J., and Proctor M.C. Current status of inferior vena cava filters. Ann Vasc Surg 14 (2000) 525-528
82. Wojcik R., Cipolle M., Fearen I., Jaffe J., Newcomb J., and Pasquale M.D. Long-term follow-up of trauma patients with a vena caval filter. J Trauma 49 (2000) 839-843
83. Stein P., Kayali F., and Olson R.E. Twenty-one-year trends in the use of inferior vena cava filters. Arch Intern Med 164 (2004) 1541-1545
84. Antevil J.L., Sise M.J., Sack D.I., et al. Retrievable vena cava filters for preventing pulmonary embolism in trauma patients: a cautionary tale. J Trauma 60 (2006) 35-40
85. Neeman Z., Auerbach A., and Wood B.J. Metastatic involvement of a retrieved inferior vena cava filter. J Vasc Interv Radiol 14 (2003) 1585
86. Gatti A.M., and Montanari S. Retrieval analysis of clinical explanted vena cava filters. J Biomed Mater Res B Appl Biomater 77 (2006) 307-314